- In April 2024, Beiersdorf, the German multinational known for its personal-care products, announced a major research breakthrough revealing that glycation accelerates skin aging by reducing elasticity and promoting wrinkles. After a decade of intensive research and testing over 1,700 active ingredients, Beiersdorf developed a patented anti-aging compound designed to protect collagen from this "sugar damage." This innovative compound promises to advance anti-aging skincare solutions by addressing the harmful effects of glycation on the skin
- In July 2023, L’Oréal S.A. acquired Youth Sciences International (YSI), enhancing its portfolio with advanced anti-aging skincare ingredients and technologies, particularly those focused on targeting AGEs. This acquisition strengthens L’Oréal’s research and development efforts, enabling the creation of more innovative anti-aging products. The move underscores L’Oréal’s commitment to expanding its expertise in AGE-related skincare solutions and advancing its position in the competitive beauty industry
- In April 2023, Shiseido Company launched the WASO Bihada Lock Moisturizer, formulated with ingredients specifically designed to prevent the formation of AGEs and protect the skin from damage. The lightweight, non-greasy formula makes it suitable for all skin types. This product exemplifies Shiseido’s commitment to offering skincare solutions that address aging concerns and support skin health
- In March 2023, Beiersdorf AG introduced the NIVEA Hyaluron Cellular Filler Anti-Age Day Cream, designed to reduce wrinkles and fine lines. The cream contains hyaluronic acid along with other key ingredients that help protect the skin from AGE-related damage. This launch highlights Beiersdorf’s focus on combining advanced skincare technology with anti-aging benefits for healthier, more youthful-looking skin
- In August 2022, a multinational study conducted by researchers from IARC, University of Vienna, and Maastricht University analyzed data from over 450,000 participants across Europe. The study concluded that higher dietary intake of advanced glycation end products (AGEs) is not associated with an increased risk of overall cancer or most specific cancer types examined. This finding challenges previous assumptions, offering new insights into the potential health impacts of AGEs in the diet
Frequently Asked Questions
The market is segmented based on Global Advanced Glycation End Products (AGEs) Market Segmentation, By Type (Non-fluorescent AGEs, Fluorescent AGE, and Others), Indication (Diabetes, Neoplasm, Orthopedic Disorder, Neurodegenerative Disorder, and Others), End User (Hospitals, Homecare, Specialty Clinics, and Others) – Industry Trends and Forecast to 2032
.
The Global Advanced Glycation End Products Ages Market size was valued at USD 1.70 USD Billion in 2024.
The Global Advanced Glycation End Products Ages Market is projected to grow at a CAGR of 7.2% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
